HIMSS TV: Etiometry on AI’s role in clinical decision support

News and Press Releases

In this HIMSS TV interview, Etiometry CEO Shane Cooke dives into the transformative role of AI in clinical decision support—not as a replacement for clinicians, but as a powerful tool to enhance their expertise. Watch the full interview to see how he breaks down how predictive analytics can detect patient deterioration earlier, why AI-driven insights help optimize critical care decisions in real time, and the future of data-driven healthcare and its impact on patient outcomes.

HIMSS TV Thumbnail

Related

Etiometry Significantly Enhances Platform Capabilities, ExtendingInsights Beyond the ICU

The addition of high-fidelity waveform data integration provides deeper insights and additional data points available in lower-acuity settings June 8, 2025 – BOSTON – Etiometry, a leader in clinical decision support software, has announced a significant advancement to its platform with the integration of high-fidelity waveform data to inform and improve existing clinical data interpretation. […]

Multicenter Study Demonstrates 29% Reduction in Vasoactive Infusion Time with Use of Etiometry’s AI Powered Clinical Intelligence Platform

Study published in Critical Care Medicine highlights impact of IDO2-informed decision support on reducing postoperative support duration June 17, 2025 – BOSTON – A newly published multicenter clinical trial in Critical Care Medicine shows that use of Etiometry’s Clinical Intelligence Platform—specifically its Inadequate Delivery of Oxygen (IDO2) Index—was associated with a significant reduction in the […]

Boston Children’s Hospital Multi-center Study Finds Etiometry’s Risk Analytics Algorithms May Help Assess Extubation Failure Following Congenital Cardiac Surgery

Results published in Pediatric Critical Care Medicine demonstrate that the IDO2 and IVCO2 Indices may support more informed ventilator liberation decisions May 19, 2025 – BOSTON – A newly published multi-center study has found that Etiometry’s FDA-cleared physiologic risk analytics—IDO2 and IVCO2—were found to be associated with increased risk of extubation failure in retrospective analysis, […]